hydrogen sulfide has been researched along with Breast Neoplasms in 10 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The S-diclofenac derivatives ACS15 and ACS32 inhibited the increase in osteoclast formation induced by human MDA-MB-231 and MCF-7 and mouse 4T1 breast cancer cells without affecting breast cancer cell viability." | 7.78 | Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. ( Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A, 2012) |
| "The S-diclofenac derivatives ACS15 and ACS32 inhibited the increase in osteoclast formation induced by human MDA-MB-231 and MCF-7 and mouse 4T1 breast cancer cells without affecting breast cancer cell viability." | 3.78 | Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. ( Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A, 2012) |
| "Hydrogen sulfide (H(2)S) is a gasotransmitter that plays several roles in various tissues, including the cardiovascular system." | 1.37 | Hydrogen sulfide promotes calcium signals and migration in tumor-derived endothelial cells. ( Avanzato, D; Cruz, JE; Mancardi, D; Merlino, A; Moccia, F; Munaron, L; Pla, AF; Pupo, E; Tanzi, F, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Wang, A | 1 |
| Wang, J | 1 |
| Lu, J | 1 |
| Li, M | 1 |
| Liu, Y | 1 |
| Deng, Y | 1 |
| Pan, L | 1 |
| Fu, H | 1 |
| Han, X | 1 |
| Li, Y | 2 |
| Shi, H | 1 |
| Wang, T | 1 |
| Bianco, S | 1 |
| Mancardi, D | 2 |
| Merlino, A | 2 |
| Bussolati, B | 1 |
| Munaron, L | 2 |
| Dong, Q | 1 |
| Yang, B | 1 |
| Han, JG | 1 |
| Zhang, MM | 1 |
| Liu, W | 2 |
| Zhang, X | 1 |
| Yu, HL | 1 |
| Liu, ZG | 1 |
| Zhang, SH | 1 |
| Li, T | 1 |
| Wu, DD | 1 |
| Ji, XY | 1 |
| Duan, SF | 1 |
| Luo, W | 1 |
| Xue, H | 1 |
| Ma, J | 1 |
| Wang, L | 1 |
| Lv, M | 1 |
| Ji, MH | 1 |
| Zhuang, M | 1 |
| Tang, JH | 1 |
| Sen, S | 1 |
| Kawahara, B | 1 |
| Gupta, D | 1 |
| Tsai, R | 1 |
| Khachatryan, M | 1 |
| Roy-Chowdhuri, S | 1 |
| Bose, S | 1 |
| Yoon, A | 1 |
| Faull, K | 1 |
| Farias-Eisner, R | 1 |
| Chaudhuri, G | 1 |
| Pupo, E | 1 |
| Pla, AF | 1 |
| Avanzato, D | 1 |
| Moccia, F | 1 |
| Cruz, JE | 1 |
| Tanzi, F | 1 |
| Frantzias, J | 1 |
| Logan, JG | 1 |
| Mollat, P | 1 |
| Sparatore, A | 1 |
| Del Soldato, P | 1 |
| Ralston, SH | 1 |
| Idris, AI | 1 |
| Chattopadhyay, M | 1 |
| Kodela, R | 1 |
| Nath, N | 1 |
| Barsegian, A | 1 |
| Boring, D | 1 |
| Kashfi, K | 1 |
1 review available for hydrogen sulfide and Breast Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of endogenous hydrogen sulfide inhibition in breast cancer (Review).
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cystathi | 2021 |
9 other studies available for hydrogen sulfide and Breast Neoplasms
| Article | Year |
|---|---|
Efficient Strategy for the Synthesis and Modification of 2-Hydroxyethylluciferin for Highly Sensitive Bioluminescence Imaging of Endogenous Hydrogen Sulfide in Cancer Cells and Nude Mice.
Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Female; Humans; | 2019 |
Hypoxia and hydrogen sulfide differentially affect normal and tumor-derived vascular endothelium.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Endothelium, V | 2017 |
A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways.
Topics: Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Enzyme Inhibitors; Female; Human | 2019 |
Molecular engineering of a colorimetric two-photon fluorescent probe for visualizing H
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Beer; Breast Neoplasms; Cell Line, Tumor; Colorimetry; Fluore | 2019 |
Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression.
Topics: Alkynes; Breast Neoplasms; Cell Movement; Cell Survival; Cystathionine gamma-Lyase; Epithelial-Mesen | 2014 |
Role of cystathionine β-synthase in human breast Cancer.
Topics: Animals; Breast Neoplasms; Cell Membrane; Coculture Techniques; Cystathionine beta-Synthase; Female; | 2015 |
Hydrogen sulfide promotes calcium signals and migration in tumor-derived endothelial cells.
Topics: Breast Neoplasms; Calcium; Carcinoma, Ductal, Breast; Cell Movement; Cell Proliferation; Dose-Respon | 2011 |
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Differentiation; | 2012 |
Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; Cell Line, Tumor; Cell Prolife | 2012 |